Meeting
2017 Gastrointestinal Cancers Symposium
Aspirin in the prevention of colorectal cancer recurrence.
Authors
Nimisha Kumari
Calvary Mater Newcastle, New Lambton, Australia
Nimisha Kumari , Hiren A. Mandaliya , Tiffany Evans , Patrick McElduff , Christopher Oldmeadow , Fiona Lee Day
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 578)
DOI
10.1200/JCO.2017.35.4_suppl.578
Abstract #
578
Poster Bd #
C18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Impact of previous adjuvant oxaliplatin combination therapy on survival in elderly colorectal cancer patients with recurrence.
First Author: Yusuke Nagata
Poster
2021 ASCO Annual Meeting
JCOG1805 (PanDRa-BD study): A randomized controlled study of adjuvant chemotherapy for stage II colorectal cancer patients at high-risk of developing recurrence according to T-stage and three selected pathological factors (Pn, DR, and BD).
First Author: Megumi Ishiguro
Poster
2021 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy (AC) choices: An analysis of elderly Australian patients with stage III colorectal cancer (CRC).
First Author: Oliver Piercey
Poster
2020 ASCO Virtual Scientific Program
TRACC: Tracking mutations in cell-free DNA to predict relapse in early colorectal cancer—A randomized study of circulating tumour DNA (ctDNA) guided adjuvant chemotherapy versus standard of care chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer (CRC).
First Author: Gayathri Anandappa